Complex formation of the anti-inflammatory drugs tenoxicam and piroxicam with Fe(III) in methanol and acetone

被引:10
|
作者
Moya-Hernandez, Rosario [2 ]
Gomez-Balderas, Rodolfo [2 ]
Mederos, Alfredo [3 ]
Dominguez, Sixto [3 ]
Teresa Ramirez-Silva, Maria [1 ]
Rojas-Hernandez, Alberto [1 ]
机构
[1] Univ Autonoma Metropolitana Iztapalapa, Dept Quim, Area Quim Analit, Mexico City 09340, DF, Mexico
[2] Univ Nacl Autonoma Mexico, Fac Estudios Super Cuautitlan, Lab Fisicoquim Analit, Unidad Invest Multidisciplinaria, Edo De Mexico, Mexico
[3] Univ La Laguna, Dept Quim Inorgan, Fac Farm, Tenerife, Islas Canarias, Spain
关键词
Fe(III)-oxicam complexes; Formation constants; Program SQUAD; Nonaqueous solvents; Spectrophotometric study; METAL-COMPLEXES; COBALT(II); NICKEL(II); COPPER(II); IRON(III); ZINC(II);
D O I
10.1080/00958970802474870
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
A spectrophotometric study of the chemical coordination of two nonsteroidal anti-inflammatory drugs (tenoxicam and piroxicam) with Fe(III) has been undertaken in methanol in order to determine the stoichiometry and formation constants of the formed complexes, 1 : 1 and 1 : 2 stoichiometric ratios [Fe(III) : oxicam]. The formation constants determined with the aid of the program SQUAD, at 293 K in methanol, are: Fe(tenox), log 11 = 4.71 0.03; Fe(tenox)2, log 12 = 8.57 0.04; Fe(pirox), log 11 = 5.54 0.09; Fe(pirox)2, log 12 = 9.75 0.08. However, the study in acetone gave rise to complexes with completely different stoichiometric ratios with polynuclear species [dimers of Fe(III)]. The formation constants determined with the aid of program SQUAD, at 293 K in acetone, are: Fe2(tenox), log 21 =9.04 0.03; Fe2(tenox)2, log 22 = 14.75 0.06; Fe2(tenox)3, log 23 = 18.45 0.07; Fe2(pirox), log 21 = 9.06 0.30; Fe2(pirox)2, log 22 = 14.77 0.09; Fe2(tenox)3, log 23 = 18.48 0.40. Besides the well-known effect of the solvent on thermodynamic constants, the stoichiometry seems to be strongly driven by the nature of the solvent.
引用
收藏
页码:40 / 51
页数:12
相关论文
共 50 条
  • [31] Anti-inflammatory drugs and the kidney
    House, A. A.
    Oliveira, S. Silva
    Ronco, C.
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2007, 30 (12): : 1042 - 1046
  • [32] ANALGESIC ANTI-INFLAMMATORY DRUGS
    CHAMPION, GD
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1975, 5 (06): : 583 - 584
  • [33] ANTI-INFLAMMATORY DRUGS AS ANTIBIOTICS
    不详
    CHEMICAL & ENGINEERING NEWS, 2014, 92 (11) : 35 - 35
  • [34] ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY
    CREWS, SJ
    PRACTITIONER, 1966, 197 (1177) : 36 - &
  • [35] Nonsteroidal anti-inflammatory drugs
    Tseng, CC
    Wolfe, MM
    MEDICAL CLINICS OF NORTH AMERICA, 2000, 84 (05) : 1329 - +
  • [36] Nonsteroidal anti-inflammatory drugs
    Moses, VS
    Bertone, AL
    VETERINARY CLINICS OF NORTH AMERICA-EQUINE PRACTICE, 2002, 18 (01) : 21 - +
  • [37] HEPATITIS DUE TO NON-STEROIDAL ANTI-INFLAMMATORY DRUGS - A NEW MOLECULE INVOLVED, PIROXICAM (FELDENE)
    ZARSKI, JP
    AUBERT, H
    DENTANT, L
    RACHAIL, M
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1984, 8 (12): : 980 - 981
  • [38] METABOLIC-FATE OF TENOXICAM AND A POSSIBLE MECHANISM OF ANTI-INFLAMMATORY ACTIVITY
    ICHIHARA, S
    ICHIHARA, Y
    NAKAYAMA, S
    TOMISAWA, H
    FUKAZAWA, H
    SUZUKI, T
    KURUMA, I
    TATEISHI, M
    JOURNAL OF PHARMACOBIO-DYNAMICS, 1985, 8 (06): : S158 - S158
  • [39] Anti-inflammatory activity and gastric lesions induced by zinc-tenoxicam
    Nascimento, JWL
    Santos, LH
    Nothenberg, MS
    Coelho, MM
    Oga, S
    Tagliati, CA
    PHARMACOLOGY, 2003, 68 (02) : 64 - 69
  • [40] Interaction of antihypertensive drugs with anti-inflammatory drugs
    Polonia, J
    CARDIOLOGY, 1997, 88 : 47 - 51